In this article, we will be looking at the top 5 stock picks of Hal Mintz’s Sabby Capital. If you want to see our comprehensive analysis of Mintz’s history and hedge fund performance, go directly to Top 10 Stock Picks of Hal Mintz’s Sabby Capital.
5. Cocrystal Pharma, Inc. (NASDAQ:COCP)
Sabby Capital’s Stake Value: $5.42 million
Percentage of Sabby Capital’s 13F portfolio: 0.73%
Total Number of Hedge Fund Holders: 5
Ranking 5th on Hal Mintz’s list of top stocks to buy is Cocrystal Pharma, Inc. (NASDAQ: COCP), a biotechnology company focusing on the discovery and development of anti-viral therapeutic drugs. Hal Mintz owns 5,165,416 shares in Cocrystal Pharma, Inc. (NASDAQ: COCP), at a value of $5.42 million.
For the third quarter of 2021, Cocrystal Pharma, Inc. (NASDAQ: COCP) reported an EPS of -$0.04, which was in-line with consensus estimates.
According to the latest data tracked by Insider Monkey for Q3 2021, 5 hedge funds out of 867 reported owning $7.86 million worth of shares in Cocrystal Pharma, Inc. (NASDAQ: COCP).
4. Barclays PLC (NYSE:BCS)
Sabby Capital’s Stake Value: $11.13 million
Percentage of Sabby Capital’s 13F portfolio: 1.5%
Total Number of Hedge Fund Holders: 12
Barclays PLC (NYSE: BCS) is a banking holding company based in the United Kingdom that provides banking, wealth management and various financial services around the globe.
On November 2, research firm Morgan Stanley kept its ‘Equal Weight’ rating on Barclays PLC (NYSE: BCS) stock, raising the price target to 240 GBP from 205 GBP.
In Q3 2021, 12 hedge funds held positions worth $105.77 million in Barclays PLC (NYSE: BCS), in contrast to 11 hedge funds holding positions worth $119.95 million in the previous quarter.
3. Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
Sabby Capital’s Stake Value: $12.95 million
Percentage of Sabby Capital’s 13F portfolio: 1.75%
Total Number of Hedge Fund Holders: 10
Next up is Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a commercial biopharmaceutical company which develops therapies for autoimmune, cancer, viral and neurodegenerative diseases. The company is based in California, and operates through its two segments: Sorrento Therapeutics and Scilex.
For the third quarter of 2021, Sorrento Therapeutics, Inc. (NASDAQ: SRNE) posted an EPS of -$0.40, missing estimates by -$0.11. The company raked in $12.06 million in quarterly revenue, missing analysts’ forecasts by $4.84 million.
As of Q3 2021, 10 hedge funds out of 867 tracked by Insider Monkey reported owning positions worth $42.58 million in Sorrento Therapeutics, Inc. (NASDAQ: SRNE). This shows a bullish trend from the previous quarter where the same number of hedge funds held positions with a combined value of $39.34 million in the pharmaceutical company.
2. BIT Mining Limited (NYSE:BTCM)
Sabby Capital’s Stake Value: $16.34 million
Percentage of Sabby Capital’s 13F portfolio: 2.2%
Total Number of Hedge Fund Holders: 6
BIT Mining Limited (NYSE: BTCM) is a cryptocurrency mining company that has a combined electric power capacity of 435MW through its three hydroelectric cryptocurrency mines. The company is based in Hong Kong and was founded in 2001. BIT Mining Limited (NYSE: BTCM) also owns and operates BTC.com, including the domain name and wallet.
BIT Mining Limited (NYSE: BTCM) gained 149.26% in the last year, and trades with a market cap of $493.06 million.
6 hedge funds reported owning positions in BIT Mining Limited (NYSE: BTCM) in the third quarter of 2021. The combined value of these holdings stood at $32.29 million.
1. Bit Digital, Inc. (NASDAQ:BTBT)
Sabby Capital’s Stake Value: $30.48 million
Percentage of Sabby Capital’s 13F portfolio: 4.12%
Total Number of Hedge Fund Holders: 4
Bit Digital, Inc. (NASDAQ: BTBT) is another company engaged in the mining of cryptocurrency. It ranks 1st on Hal Mintz’s list of top stocks to buy. Mintz’s fund Sabby Capital owns 4,216,310 shares in the crypto-mining business, according to the data for the third quarter.
On September 23, research firm HC Wainwright & Co initiated its coverage on Bit Digital, Inc. (NASDAQ: BTBT) with a ‘Buy’ rating and a $14 price target.
As of the third quarter of 2021, 4 hedge funds reported positions in Bit Digital, Inc. (NASDAQ: BTBT). The combined value of these stakes stood at $69.21 million.
You can also take a peek at the 10 Best Dividend Stocks to Buy According to Billionaire Howard Marks and 12 Best Autonomous Vehicle Stocks to Buy for 2021.
